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nanoneedles,[3–9] have demonstrated a 
broad versatility to efficiently sense[2] and 
deliver[10] to the cell interior. Successful 
delivery of exogenous materials in the form 
of nucleic acids,[4,5,9] proteins,[5] metabo-
lites,[11] and cell-impermeable[12] nanopar-
ticles by nanoneedle arrays, has now been 
independently demonstrated for a broad 
range of geometries, material composi-
tions, and cell types. Moreover, the intimate 
interface established with the cell mem-
brane has enabled nanoneedles to sense 
proteins,[13] metabolites,[14] and lipids[15] in 
the intracellular milieu as well as to stim-
ulate and record action potentials of large 
arrays of individual excitable cells.[7,16,17] 
Nanoneedle arrays promise to be a safe and 
effective platform for nucleic acid delivery 
that compares favorably with microinjec-
tion and electroporation, thanks to its ease 
of use, high throughput, elevated biocom-
patibility, and efficient delivery.
Despite rapid advances that culmi-
nated with their first use for in situ gene 
therapy,[9] there is a need to improve the 
understanding of nanoneedle-mediated 
delivery in order to rationally design plat-
forms for efficient clinical translation. 
Biomolecules delivered from nanoneedles display biological 
activity, highlighting an underlying mechanism that traffics 
them to their target site of action either in the cytosol (siRNA,[9] 
Owing to their ability to efficiently deliver biological cargo and sense the 
intracellular milieu, vertical arrays of high aspect ratio nanostructures, 
known as nanoneedles, are being developed as minimally invasive tools 
for cell manipulation. However, little is known of the mechanisms of cargo 
transfer across the cell membrane-nanoneedle interface. In particular, the 
contributions of membrane piercing, modulation of membrane permeability 
and endocytosis to cargo transfer remain largely unexplored. Here, combining 
state-of-the-art electron and scanning ion conductance microscopy with 
molecular biology techniques, it is shown that porous silicon nanoneedle arrays 
concurrently stimulate independent endocytic pathways which contribute 
to enhanced biomolecule delivery into human mesenchymal stem cells. 
Electron microscopy of the cell membrane at nanoneedle sites shows an intact 
lipid bilayer, accompanied by an accumulation of clathrin-coated pits and 
caveolae. Nanoneedles enhance the internalization of biomolecular markers of 
endocytosis, highlighting the concurrent activation of caveolae- and clathrin-
mediated endocytosis, alongside macropinocytosis. These events contribute to 
the nanoneedle-mediated delivery (nanoinjection) of nucleic acids into human 
stem cells, which distribute across the cytosol and the endolysosomal system. 
This data extends the understanding of how nanoneedles modulate biological 
processes to mediate interaction with the intracellular space, providing 
indications for the rational design of improved cell-manipulation technologies.
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Gaining access to the intracellular space with minimal toxicity 
is a key feature in developing efficient strategies for drug 
delivery[1] and intracellular sensing.[2] Vertical high-aspect ratio 
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proteins,[5] or peptides[13]) or in the nucleus (plasmid DNA[9]). 
This evidence of efficient delivery led to the initial assump-
tion that nanoneedles traversed the cell membrane to directly 
deliver biomolecules into the cytoplasm. Pioneering studies 
with atomic force microscopy (AFM) operated nanoneedles 
supported this assumption, showing systematic drops in the 
force–displacement curve during interaction with synthetic 
lipid bilayers[18,19] and membranes of cells in culture,[20–23] 
attributed to breaching of the cell membrane. The local 
quenching of green fluorescent protein (GFP) fluorescence 
upon nanoneedle delivery of membrane-impermeant Co2+ ions 
supported this view.[24]
Yet, direct evidence from microscopy analysis of the 
cell-nanoneedle interface, invariably showed an intact cell 
Figure 1. Cell membrane response to nanoneedle (nN) interfacing. a) Nanoneedle interfacing induces membrane ruffling. 3D SICM image of an 
hMSC cultured on nanoneedles (top) or FSW (bottom) for 6 h (left). A zoomed-in 2D SICM scan (10 × 10 µm) (middle) and SEM image of the apical 
membrane (right). Scale bars = 5 µm. b,c) Nanoneedle interfacing increases membrane roughness. Surface roughness (b) Rrms and (c) Ra of apical 
membrane of hMSCs on nanoneedles compared to FSW measured by SICM. Box plot shows center line as median, first and third quartile data range, 
and whiskers to minimum and maximum. ****p < 0.0001 (two-tailed unpaired Student's t-test), n = 8 cells for nN and n = 11 cells for FSW. d,e) Cell 
membrane integrity is observed at the nanoneedle interface. C = cytosol, V = vesicle, N = nucleus, M = membrane. (d) Representative FIB-SEM image 
of an orthogonal cross section of an hMSC on nanoneedles after 6 h of interfacing. Scale bar = 2 µm. (e) TEM of FIB lift-out thin sections of the hMSC-
nanoneedle interface. Clockwise: overview of a representative nanoneedle; nanoneedle side; vesicle located at the side of a nanoneedle; nanoneedle 
top. Scale bar = 200 nm.
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membrane around the nanostructures. Transmission electron 
microscopy (TEM) analysis of cells on lower aspect nanonee-
dles displayed a continuous cell membrane wrapping around 
all the pillars observed.[25] Similarly, studies of nanoneedles of 
different geometries and surface chemistries showed that at 
least 95% of the nanoneedles were enclosed within a mem-
brane, with a determination not possible only in the case of four 
amino-silane-coated nanoneedles.[26] In agreement with this 
data, a more recent microscopy study showed cell membrane 
wrapping around nanoneedles of a range of lateral dimensions 
between 80 nm and 1 µm.[27] Further, all recent attempts using 
nanoneedles to sense intracellular potentials in excitable cells, 
agree on the need for an initial electroporation or optoporation 
in order to gain access to the cytosol, and that such access is 
only temporary, albeit much longer than conventional clamping 
methods.[7,16,27,28] Raman spectroscopy also allowed identifying 
the initial presence of a membrane wrapping around SERS 
active hollow nanoneedles, its disruption upon poration and 
the ensuing resealing process, that led to changes in mem-
brane composition.[15] Overall these findings indicate that a 
simple membrane penetration model does not fully describe 
the uniqueness and complexity of the cell-nanoneedle interface, 
calling for more in-depth investigations of its nature, and of the 
mechanisms that enable intracellular delivery.
For instance, we must consider the crucial role played by 
endocytosis in trafficking cargo from the cell membrane, a 
dynamic and complex system that is highly responsive to 
external signals, both mechanical and biochemical. Indeed, 
deforming the cell membrane, as nanoneedles do, can modu-
late the local composition of lipids and proteins,[29] inducing 
the accumulation of intracellular scaffolding structures that ini-
tiate clathrin or caveolae-mediated endocytosis.[30] High-aspect 
nanostructures that locally deform the membrane can accu-
mulate scaffolding proteins and endocytic pits.[31–33] However, 
the contribution of endocytosis to biomolecule delivery from 
nanoneedles, and its role on determining the fate of the pay-
load still needs to be clarified.
In this study, we investigate the interface between the cell 
membrane and recently developed porous silicon nanonee-
dles[9,12] in relation to their capacity to deliver biological payloads 
in human mesenchymal stem cells (hMSCs). In particular, we 
assess the ability of porous silicon nanoneedles to deliver bio-
logical cargo via endocytosis, while negotiating the cell mem-
brane using a variety of state-of-the-art microscopy techniques. 
Moreover, we study the fate of the delivered pathway-specific 
cargo within the cytoplasm, highlighting the significant role 
of endocytic pathways in nanoneedle-mediated delivery (nano-
injection). Finally, the significant endolysosomal trafficking of 
nanoneedle-injected siRNA highlights a role for endocytosis in 
nucleic acid uptake, while concurrently validating its cytosolic 
delivery and biological activity by gene silencing. These results 
provide fundamental insight into the contribution of topo-
graphic stimuli on intracellular delivery in nonendocytic cells, 
which has implications for the design of next generation stem 
cell manipulation strategies involving intracellular biomolecule 
delivery and interrogation.
In order to assess the membrane response to interfacing 
with porous silicon nanoneedles, the apical membrane mor-
phology of hMSCs was visualized on nanoneedle arrays and 
flat silicon substrates using a combination of electron and scan-
ning ion conductance microscopy (SICM) techniques. SICM 
enabled label-free, noninvasive mapping of the topography of 
the apical cell membrane in its native state[34–36] (Figure S1a, 
Supporting Information). After 6 h of culture, the apical sur-
face of hMSCs on nanoneedles showed numerous protrusions 
in random orientations akin to dorsal membrane ruffles seen 
in cells actively participating in macropinocytosis (MP)[37] and 
remodeling their actin cytoskeleton[38] (Figure 1a and Figure 
S1b,c, Supporting Information). It is in these regions that 
actin-related protein 2/3 (ARP2/3) complexes and vesicle scis-
sion proteins such as dynamins are known to localize.[39] Mem-
brane ruffling led to a 1.8-2-fold increase in surface roughness 
(Rrms and Ra) of the apical membrane of cells interfaced with 
nanoneedles compared to those cultured on flat silicon wafers 
(FSW) (Figure 1b,c). To characterize the morphology of the 
basal membrane in contact with the nanoneedles, we used a 
recently developed focused ion beam scanning electron micros-
copy (FIB-SEM) approach[9,40] for in situ slice-and-view[40,41] 
(Figure 1d and Figure S2a–e, Supporting Information), along-
side analysis of resin-embedded sections by TEM (Figure 1e 
and Figure S3, Supporting Information). FIB-SEM showed 
the basal membrane of hMSCs wrapping around individual 
nanoneedles without discontinuities evident at 20 nm resolu-
tion (Figure S2d,e, Supporting Information). Higher resolu-
tion TEM micrographs of FIB-milled sections showed extreme 
vicinity (in the order of nanometers) between the nanoneedles 
and the membrane at the interface and confirmed membrane 
continuity at 4 nm resolution (Figure 1e).
In the absence of visible membrane penetration or discon-
tinuities for long-term interfacing, and given the observed 
membrane ruffling, endocytosis represents a viable mechanism 
that can contribute to payload delivery. Immunofluorescence 
Figure 2. Nanoneedles locally activate endocytosis. a–d) Caveolin-1 (Cav-1) accumulates around nanoneedles. a,b) Confocal fluorescence images of 
caveolin-1 after 6 h in the (a) apical and (b) basal membrane of hMSCs cultured on nanoneedles or FSW and their respective line intensity profiles 
over the cells. Arrows in line intensity plots indicate 2 µm intervals matching the distance between individual nanoneedles. c,d) Upon interfacing, Cav-1 
at the basal membrane acquires the same periodicity as the nanoneedles as assessed by Fourier transform analysis of the basal surface of hMSCs 
in panels (a) and (b). e,f) Clathrin accumulates around nanoneedles. Confocal fluorescence images of CLC after 6 h in the (e) apical and (f) basal 
membrane of hMSCs cultured on nanoneedles or FSW and their respective intensity profiles along the dashed lines. g,h) Upon interfacing, clathrin at 
the basal membrane acquires the same periodicity as nanoneedles as assessed by Fourier transform analysis of the basal surface of hMSCs in panels 
e and f. Scale bars = 10 µm. i–k) Endocytic vesicles accumulate around nanoneedles. (i) FIB-SEM image interface showing two classes of endocytic 
vesicles accumulating around nanoneedles: clathrin pits (orange arrows) and caveolae (green arrows). Scale bars = 100 nm. (j) 3D reconstruction of the 
cell-nanoneedle interface over two consecutive rows of nanoneedles highlighting vesicular structures present in the membrane at nanoneedle (red) and 
non-nanoneedle (blue) locations. (k) Quantification of vesicular invaginations in the membrane from FIB-SEM data at nanoneedle and non-nanoneedle 
locations. Plot shows mean ± S.D., N = 4, n = 11 (cells), ****p < 0.0001 (two-tailed unpaired Student's t-test).
www.advmat.dewww.advancedsciencenews.com
1806788 (5 of 8) © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Mater. 2019, 31, 1806788
Figure 3. Nanoinjection enhances the uptake of pathway-specific cargo, which localizes within the endolysosomal system. a) Nanoinjection enhances 
uptake of Tfn, CTxB, and Dex of different sizes. Flow cytometry analysis showing the percentage of positive cells successfully internalizing pathway 
specific payloads by nanoinjection or FSW delivery at 24 h. Clockwise – Tfn, a clathrin-mediated endocytosis cargo, CTxB, a caveolae-specific cargo, and 
Dex 10, 40, 70 kDa, Macropinocytosis-specific cargo. Data presented as median with interquartile range. N = 3, n = 2 **p = 0.0022 for Tfn, CTxB, Dex 
10, Dex 70 kDa and **p = 0.0079 for Dex 40 kDa (Mann–Whitney test). b) Tfn fate. Representative confocal images of a plane above the nanoneedles 
and quantification of Tfn (green) colocalization with CLC, EEA1 and LAMP1 at 24 h. c) Cholera Toxin fate. Representative confocal images of a plane 
above the nanoneedles and quantification of CTxB colocalization with Cav-1, EEA1 and LAMP1 at 24 h. d) Dex fate. Representative confocal images of 
a plane above the nanoneedles and quantification of Dex 10 kDa colocalization with EEA1 and LAMP1 at 24 h. Quantified data represented scatter dot 
plots with bars representing mean ± S.D., N = 1, n = 3 biological replicates, at least five images per n. Scale bars = 20 µm. e) Quantification of Tfn, 
CTxB and Dex 10 kDa localization with their pathway-specific endocytosis carriers and trafficking components (Tfn with CLC, EEA1 and LAMP1, CTxB 
with Cav-1, EEA1 and LAMP1 and Dex10 with EEA1 and LAMP1). Quantified data presented as scatter dot plots with bars representing mean ± S.D., 
N = 1, n = 3 biological replicates, at least five images per n.
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analysis highlighted the localization of 
caveolin-1 (CAV-1, Figure 2a–d), a key pro-
tein involved in caveolae-mediated endocy-
tosis (CavME) and clathrin light chain (CLC, 
Figure 2e–h), a clathrin coat protein for 
clathrin-mediated endocytosis (CME) after 
6 h of interfacing. Both CAV-1 and CLC colo-
calized with nanoneedles at the basal mem-
brane, as they clustered with periodic inten-
sity. Fourier transform analysis confirmed 
that the period (1.967 +/− 0.05 µm) matched 
the nanoneedle spacing (2 µm) (Figure 2d,h). 
The same proteins at the apical membrane 
were unaffected by the nanoneedles and we 
observed no periodicity basally or apically 
for hMSCs on FSW (Figure 2c,g). Moreover, 
the total protein expression levels of CAV-1 
and CLC did not increase on nanoneedles 
suggesting that this response is local to the 
membrane-nanoneedle interface (Figure S4, 
Supporting Information). Indeed, FIB-SEM 
analysis confirmed the assembly of these 
endocytic proteins into spherical-coated pits 
and flask shaped invaginations in the size 
range of clathrin-coated pits (CCP) and cave-
olae (Figure 2i and Figure S2e, Supporting 
Information), and their preferential accumu-
lation near the tips and sides of the nanon-
eedles (Figure 2j,k). Previous reports of cells 
cultured on nanopillars suggest that caveolae 
are not sensitive to membrane curvature.[31] 
However electron microscopy, confocal 
imaging, and delivery of caveolae-specific 
cargo in our system indicate that caveolae are 
key players during interfacing, most likely 
through their ability to sense membrane ten-
sion rather than curvature in a mechanically 
stressed environment.[42] These data indicate 
that nanoneedles induce local membrane 
deformation that accumulates functional 
endocytic vesicles.
Given the accumulation of endocytic 
vesicles at the nanoneedle interface and 
Figure 4. Nanoinjected siRNA partly localizes across the endolysosomes while retaining 
cytosolic activity. a,b) Nanoinjection enhances siRNA delivery. (a) Maximal Z-stack projection 
of hMSCs above the nanoneedles showing fluorescently labeled Cy3-siRNA-GAPDH (green) 
in the cell after 24 h of interfacing. (b) Flow cytometry data of Cy3-siRNA uptake in hMSCs 
mediated by nanoneedles compared to FSW after 
24 h. Box plot shows center line as median, first and 
third quartile data range, and whiskers to minimum 
and maximum. **p = 0.0022 (Mann–Whitney test), 
N = 4, n = 2. c–f) Representative confocal images 
of Cy3-siRNA colocalization with (c) CLC, (d) Cav-1, 
(e) EEA1, and (f) LAMP1. Scale bars = 20 µm. g) 
Colocalization of endocytic carrier proteins (CLC, 
Cav-1), endosomes (EEA1) and late endosomes/ 
lysosomes (LAMP1) and their combination (All) with 
Cy3-siRNA. Values reported as aligned scatter plot 
of percentages of Cy3-siRNA pixels overlapping with 
indicated components of the endolysosomal system 
(Mander's coefficient). Lines represent mean ± S.D. 
N = 3, n = 2 for LAMP1, EEA1, N = 3, n = 1 for CLC, 
Cav-1. —Five to ten images per sample.
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the membrane ruffling, we investigated whether and to what 
extent nanoneedles stimulated specific endocytic pathways. We 
assessed CME by Transferrin (Tfn) uptake, CavME by internali-
zation of Cholera toxin B-subunit (CTxB) and MP by uptake of 
Dextran (Dex) chains in the size range of 10 to 70 kDa (Figure 3a, 
clockwise). We measured the adsorption efficiency of Tfn, CTxB, 
and Dex to find that these cargoes adsorbed in similar amounts 
on nanoneedles and FSW suggesting that the maximal loading 
of the nanoneedle substrate is dependent on the size and charge 
of the cargo, nanoneedle pore size and surface charge rather 
than total surface area (Figure S5, Supporting Information). 
After 24 h, Tfn, CTxB and Dex 10, 40, and 70 kDa were all inter-
nalized more efficiently by cells cultured on nanoneedle arrays 
compared to FSW as indicated by the significant increase in the 
percentage of positive cells for each of the cargo (Figure 3a and 
Figure S7–S11, Supporting Information).
In order to assess the proportion of endocytic cargo that 
enters the endolysosomal system during nanoneedle-medi-
ated delivery, we assessed biomolecules known to internalize 
through specific endocytic pathways for their colocalization 
with early endosomes and lysosomes. In addition, we deter-
mined the colocalization of Tfn (known to enter by CME) 
against CLC, and the colocalization of CTxB (known to enter 
by CavME) with Cav-1 at 24 h. At this point the nanoneedles 
have degraded[9] and no array-like pattern of Cav-1 and CLC was 
observed. Tfn colocalized with CLC (46 ± 16%) and lysosome-
associated membrane protein 1 (LAMP1) (49 ± 20%) and Early 
Endosome Antigen 1 (EEA1, 33 ± 12%), indicating that Tfn 
may be recycled to the cell surface (associated with CLC at cell 
surface) and trafficked into lysosomes (Figure 3b). The extent 
of colocalization for CME and CavME cargoes with endolyso-
somal compartments and carrier proteins was highly variable. 
For instance, the colocalization of CTxB with its carrier Cav-1 
and with EEA1 ranged from below 20% in some cases to above 
90% in others (Figure 3c, graph panel). This variation suggests 
that nanoneedles enable sustained delivery of CTxB resulting 
in cargo at different stages of trafficking along each pathway. 
CTxB however colocalized highly with LAMP1, suggesting that 
CavME stimulated by nanoneedles accumulated within lys-
osomes. Unsurprisingly, Dex showed highly consistent degrees 
of colocalization with endosomes and lysosomes (20–30%), 
possibly owing to the fact that macropinocytosis occurs from 
the apical cell surface and relies on release of fluid phase 
markers into the surrounding media for internalization rather 
than from the basal cell surface in contact with the nanoneedles 
(Figure 3d). Lastly, we assessed the fate of each of these cargoes 
within the endolysosomal system by combining their colocali-
zation with respective carriers, endosomes and lysosomes to 
find that CTxB was trafficked into the endolysosomal system to 
the greatest extent (65 ± 20%), followed by Tfn (45 ± 17%), and 
Dex (38 ± 11%) (Figure 3e). This indicates that specific endo-
cytic pathways are activated by nanoneedles, and account for a 
significant fraction, but not the entirety, of the total delivery of 
cargo-specific payload.
If endocytosis is the key mechanism of internalization by 
nanoinjection, the entrapment of biofunctional payloads within 
the endolysosomal system could hamper their functionality. 
To test this hypothesis we investigated the trafficking of nano-
injected siRNA targeting GAPDH and probed its biological 
activity, which relies on the colocalization of nondegraded 
siRNA with the RNA-induced silencing complex (RISC) in the 
cytosol.[43] Indeed, nanoinjection significantly improved intracel-
lular delivery of siRNA-GAPDH (Figure 4a). After 24 h of inter-
facing, the siRNA localized in the cytoplasm of hMSCs with a 
considerable amount of punctate signal, typically in the perinu-
clear region (Figure 4b). siRNA could be seen colocalizing with 
Cav-1, CLC, EEA1, and LAMP1 to different extents (Figure 4c–f), 
and its colocalization with these components was quantified. An 
average of 45 ± 13% of siRNAs colocalized with Cav-1, 34 ± 9% 
of siRNAs colocalized with CLC, 44 ± 14% of siRNA with EEA1 
and 40 ± 13% of the siRNAs were entrapped within LAMP1 
positive lysosomes, indicating that a substantial percentage 
of nucleic acids enter the endolysosomal pathway (Figure 4g). 
By considering the colocalization of siRNA with the combined 
signal of EEA1, Lamp1, CLC, and Cav-1, 62 ± 16% of siRNA was 
trafficked into the endolysosomal pathway (Figure 4g). Never-
theless, nanoinjection of siRNA-GAPDH induced a statistically 
significant 43 ± 14% reduction in GAPDH expression in hMSCs 
compared to control in each experiment (N = 3, *p < 0.05, Stu-
dent’s paired t-test, Table S1, Supporting Information), indi-
cating that a proportion of the remaining 38% of nanoinjected 
siRNAs are trafficked outside of endolysosomal pathway and 
can mediate biological functions in the cytosol.
Overall, our results demonstrate that nanoneedles improve 
the internalization of pathway-specific payloads and nucleic 
acids. This delivery is at least partly mediated by endocytic pro-
cesses which are upregulated selectively at the cell-nanoneedle 
interface, leading to the endolysosomal localization of large 
proportions of the payloads. Nonetheless, a significant fraction 
of each payload (38% for siRNA) is trafficked alternatively and 
retains biological function in the cytosol. The active cytosolic 
fraction of payload could result from endosomal escape or con-
current delivery mechanisms that bypass the endolysosomal 
system. In the literature, studies of nanoneedle-mediated gene 
therapy have shown transfection efficiencies widely varying 
between 0% and > 90% depending on nanoneedle properties 
and cell type.[3–5,9,44] The engagement of specific endocytic path-
ways can regulate payload fate and could play a significant role 
in the broad differences observed. This study highlights that 
these aspects should be investigated when developing nanoin-
jection strategies in order to optimize their efficiency.
Experimental Section
Available in Supporting Information.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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